Northern Trust
SPRB

Northern Trust’s Spruce Biosciences SPRB Stock Holding History

Northern Trust’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.14M Buy
+21,083
New +$1.18M ﹤0.01% 3409
2026
Q1 		– Sell
-2,422
Closed -$211K – 4556
2025
Q4 		$211K Buy
+2,422
New +$259K ﹤0.01% 3968
2025
Q2 		– Sell
-436
Closed -$9.49K – 4521
2025
Q1 		$9.49K Sell
436
-635
-59% -$17.7K ﹤0.01% 4390
2024
Q4 		$33.7K Buy
1,071
+72
+7% +$2.64K ﹤0.01% 4319
2024
Q3 		$35.6K Hold
999
– – ﹤0.01% 4263
2024
Q2 		$38.8K Hold
999
– – ﹤0.01% 4243
2024
Q1 		$58.9K Sell
999
-290
-22% -$73.7K ﹤0.01% 4200
2023
Q4 		$283K Buy
1,289
+640
+99% +$73.9K ﹤0.01% 3749
2023
Q3 		$110K Sell
649
-112
-15% -$18.9K ﹤0.01% 3990
2023
Q2 		$123K Buy
761
+578
+316% +$96.6K ﹤0.01% 3981
2023
Q1 		$30.4K Sell
183
-5
-3% -$929 ﹤0.01% 4371
2022
Q4 		$15.4K Hold
188
– – ﹤0.01% 4527
2022
Q3 		$19K Hold
188
– – ﹤0.01% 4557
2022
Q2 		$24K Sell
188
-754
-80% -$96.6K ﹤0.01% 4595
2022
Q1 		$143K Sell
942
-58
-6% -$10.8K ﹤0.01% 4242
2021
Q4 		$334K Buy
1,000
+4
+0.4% +$1.19K ﹤0.01% 3976
2021
Q3 		$449K Sell
996
-42
-4% -$26.4K ﹤0.01% 3805
2021
Q2 		$873K Buy
1,038
+23
+2% +$24.5K ﹤0.01% 3557
2021
Q1 		$1.26M Sell
1,015
-41
-4% -$62.9K ﹤0.01% 3489
2020
Q4 		$1.93M Buy
+1,056
New +$1.75M ﹤0.01% 3216

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return

Northern Trust's SPRB Position: Q2 2026 in Review

Northern Trust opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 21,083 shares worth $1.14M. The stake represents ﹤0.01% of the portfolio and ranks #3409 among its holdings. This is a return to the name: Northern Trust previously reported a position in SPRB as recently as Q4 2025.

Northern Trust first reported a position in SPRB in Q4 2020 and has held it in 20 quarters since. The position peaked at $1.93M in Q4 2020. 57 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Northern Trust held 21,083 shares of Spruce Biosciences worth $1.14M as of Q2 2026.
  • Spruce Biosciences was a new Northern Trust position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #3409 holding.
  • Northern Trust first reported a position in Spruce Biosciences in Q4 2020 and has held it in 20 quarters since.
  • Northern Trust's Spruce Biosciences position peaked at $1.93M in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.